56 followers
Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma. https://t.co/NbPxcXMCMC
137 followers
RT @jitcancer: New #JITC Case Report: Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for…
8,138 followers
#JITC Case Report: Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma https://t.co/ogafLVlPy2 https://t.co/BIDpfyRNoH
251 followers
RT @jitcancer: New #JITC Case Report: Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for…
19,289 followers
RT @jitcancer: New #JITC Case Report: Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for…
1,734 followers
RT @jitcancer: New #JITC Case Report: Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for…
8,138 followers
New #JITC Case Report: Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma https://t.co/ogafLVlPy2 https://t.co/B22CyUbmPN
925 followers
New article: Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma. https://t.co/e9n0u80rQe #DLBCL #lymsm #hematology